Title : Pharmacodynamics and Outcomes of a De-Escalation Strategy with Half-Dose Prasugrel or Ticagrelor in East Asians Patients with Acute Coronary Syndrome: Results from HOPE-TAILOR Trial.

Pub. Date : 2021 Jun 18

PMID : 34207339






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 East Asians treated with potent P2Y12 inhibitors (prasugrel or ticagrelor) generally experience more intense platelet inhibitory responses resulting in an increased risk of major bleeding. Prasugrel Hydrochloride purinergic receptor P2Y12 Homo sapiens